Drug Type Small molecule drug |
Synonyms 3-(3'-hydroxybenzyl)amino-17-methylmorphinan, Compound 4g(Harvard Medical School) + [1] |
Action agonists |
Mechanism κ opioid receptor agonists(Kappa opioid receptor agonists), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Severe pain | Discovery | United States | 04 Apr 2012 |